These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2811495)
21. The effect of malaria infection on antipyrine metabolite formation in the rat. Mansor SM; Ward SA; Edwards G Biochem Pharmacol; 1991 Apr; 41(8):1264-6. PubMed ID: 2009102 [TBL] [Abstract][Full Text] [Related]
22. Effects of flumethrin on hepatic drug-metabolizing enzymes and antipyrine disposition in rats. Anadón A; Martinez-Larrañaga MR; Diaz MJ; Bringas P; Fernandez MC; Martinez MA; Fernandez-Cruz ML Toxicol Appl Pharmacol; 1995 May; 132(1):14-8. PubMed ID: 7747277 [TBL] [Abstract][Full Text] [Related]
24. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo. Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137 [TBL] [Abstract][Full Text] [Related]
25. Role of specific cytochrome P-450 isoenzymes in the regio-selective metabolism of 7,12-dimethylbenz[a]anthracene in microsomes from rats treated with phenobarbital or Sudan III. McCord A; Burnett AK; Wolf CR; Morrison V; Craft JA Carcinogenesis; 1988 Aug; 9(8):1485-91. PubMed ID: 3135957 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of CCl4 metabolism by oxygen varies between isoenzymes of cytochrome P-450. Burk RF; Hill KE; Lane JM Biochem Biophys Res Commun; 1988 May; 152(3):1463-7. PubMed ID: 3377780 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man. Boobis AR; Brodie MJ; Kahn GC; Toverud EL; Blair IA; Murray S; Davies DS Br J Clin Pharmacol; 1981 Dec; 12(6):771-7. PubMed ID: 7340879 [TBL] [Abstract][Full Text] [Related]
28. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography. Imaoka S; Inoue K; Funae Y Arch Biochem Biophys; 1988 Aug; 265(1):159-70. PubMed ID: 3415241 [TBL] [Abstract][Full Text] [Related]
29. Studies on rat liver cytochrome P-450s involved in the metabolism of antipyrine: phenobarbital- and 3-methylcholanthrene-inducible isozymes possessing 4-hydroxylase activity. Buppodom P; Koga N; Yamada H; Yoshimura H Biochem Pharmacol; 1986 Apr; 35(8):1404-6. PubMed ID: 3964305 [No Abstract] [Full Text] [Related]
30. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species. McManus ME; Ilett KF Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309 [TBL] [Abstract][Full Text] [Related]
31. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction. Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519 [TBL] [Abstract][Full Text] [Related]
32. Metabolism of antipyrine and sulphadimidine in dwarf goats: effects of the enzyme-inducing agents phenobarbital, troleandomycin and rifampicin. Natsuhori M; Witkamp RF; Van 't Klooster GA; Van Miert AS Xenobiotica; 1992 Nov; 22(11):1243-50. PubMed ID: 1492417 [TBL] [Abstract][Full Text] [Related]
33. Metabolism of antipyrine and m-xylene in rats after prolonged pretreatment with xylene alone or xylene with ethanol, phenobarbital or 3-methylcholanthrene. Elovaara E; Engström K; Häyri L; Hase T; Aitio A Xenobiotica; 1989 Sep; 19(9):945-60. PubMed ID: 2815836 [TBL] [Abstract][Full Text] [Related]
34. Effect of concomitant administration of cimetidine and phenobarbital on antipyrine elimination and metabolite formation. Sonne J; Døssing M; Poulsen HE; Pilsgaard H; Rasmussen B; Loft S Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):194-6. PubMed ID: 3583468 [TBL] [Abstract][Full Text] [Related]
35. The effect of velnacrine on the mixed function oxidase system. Eccles MJ; Danbury TC; Ford JM; Roberts CJ Eur J Drug Metab Pharmacokinet; 1997; 22(2):121-5. PubMed ID: 9248779 [TBL] [Abstract][Full Text] [Related]
36. Drug metabolism in rats with cancer induced by N-nitrosodiethylamine and phenobarbital. Aitio ML; Hietanen E; Béréziat JC; Arvela P; Bartsch H Pharmacol Toxicol; 1992 Jun; 70(6 Pt 1):468-74. PubMed ID: 1438025 [TBL] [Abstract][Full Text] [Related]
37. Effects of xylene exposure on the metabolism of antipyrine in vitro and in vivo in the rat. Toftgård R Toxicology; 1983 Sep; 28(1-2):117-31. PubMed ID: 6636196 [TBL] [Abstract][Full Text] [Related]
38. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator. Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137 [TBL] [Abstract][Full Text] [Related]
39. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism. Døssing M; Pilsgaard H; Rasmussen B; Poulsen HE Eur J Clin Pharmacol; 1983; 25(2):215-22. PubMed ID: 6628504 [TBL] [Abstract][Full Text] [Related]
40. [Identification of molecular forms of cytochrome P-450 isolated from liver microsomes of rats induced with phenobarbital and 3-methylcholanthrene]. Guliaeva LF; Khatsenko OG; Gerasimov KE; Mitrofanov DV; Mishin VM Biokhimiia; 1989 Mar; 54(3):487-94. PubMed ID: 2752066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]